about
Harnessing immunosurveillance: current developments and future directions in cancer immunotherapySustained proliferation in cancer: Mechanisms and novel therapeutic targetsAssessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesisUnleashing the therapeutic potential of human kallikrein-related serine proteases.DNA vaccination for prostate cancer: key concepts and considerations.Characterization of the T-cell receptor repertoire by deep T cell receptor sequencing in tissues from patients with prostate cancer.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunotherapy and immune evasion in prostate cancer.
@en
Immunotherapy and immune evasion in prostate cancer.
@nl
type
label
Immunotherapy and immune evasion in prostate cancer.
@en
Immunotherapy and immune evasion in prostate cancer.
@nl
prefLabel
Immunotherapy and immune evasion in prostate cancer.
@en
Immunotherapy and immune evasion in prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
Immunotherapy and immune evasion in prostate cancer.
@en
P2093
Archana Thakur
Lawrence G Lum
Ulka Vaishampayan
P2860
P304
P356
10.3390/CANCERS5020569
P577
2013-05-24T00:00:00Z